Laboratory assessment of unfractionated heparin (ufh) with activated clotting time (act) and anti-xa activity during peripheral arterial angiographic procedure

HIGHLIGHTS

• who: Tuukka Helin et al. from the Laboratory Assessment of Unfractionated Heparin (UFH) with Department of Clinical Chemistry, HUS Diagnostic Center, Helsinki University Hospital, POBox, Helsinki, Finland have published the paper: Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure, in the Journal: Diagnostics 2023, 1489 of /2023/
• what: The authors aimed to test the validity of standard UFH bolus immediately after the bolus and in some cases 1 h into the or a combination thereof (altogether 32 measurements). The authors aimed to assess . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.